Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) just unveiled an update.
Jiangsu Recbio Technology Co., Ltd. has established a Remuneration and Appraisal Committee to enhance its governance structure by formulating appraisal standards and remuneration plans for directors and senior management. This move aims to create a scientific and standardized incentive mechanism, potentially strengthening the company’s operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:2179) stock is a Sell with a HK$5.50 price target. To see the full list of analyst forecasts on Jiangsu Recbio Technology Co., Ltd. Class H stock, see the HK:2179 Stock Forecast page.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biotechnology sector. The company focuses on developing and enhancing its remuneration and appraisal systems to improve corporate governance.
Average Trading Volume: 39,478
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.69B
For a thorough assessment of 2179 stock, go to TipRanks’ Stock Analysis page.